Huntington National Bank’s NeoGenomics NEO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$45.5K Sell
3,122
-246
-7% -$2.37K ﹤0.01% 1468
2026
Q1
$25K Buy
3,368
+418
+14% +$4.4K ﹤0.01% 1575
2025
Q4
$34.7K Buy
2,950
+171
+6% +$1.84K ﹤0.01% 1387
2025
Q3
$21.5K Buy
2,779
+429
+18% +$3K ﹤0.01% 1580
2025
Q2
$17.2K Buy
2,350
+2,329
+11,090% +$18.8K ﹤0.01% 1627
2025
Q1
$199 Buy
21
+1
+5% +$12 ﹤0.01% 2634
2024
Q4
$330 Buy
20
+6
+43% +$93 ﹤0.01% 2572
2024
Q3
$207 Sell
14
-4
-22% -$63 ﹤0.01% 2650
2024
Q2
$250 Buy
+18
New +$255 ﹤0.01% 2555
2022
Q1
Sell
-257
Closed -$9K 2246
2021
Q4
$9K Buy
+257
New +$10.1K ﹤0.01% 1608
2021
Q2
Sell
-136
Closed -$7K 1858
2021
Q1
$7K Buy
+136
New +$7.08K ﹤0.01% 1408

Other funds holding NEO

Huntington National Bank's NEO Position: Q2 2026 in Review

Huntington National Bank reduced its NeoGenomics (NEO) stake by 7.3% in Q2 2026, selling an estimated $2.37K and leaving 3,122 shares worth $45.5K. The position accounts for ﹤0.01% of the portfolio, ranked #1468.

Huntington National Bank first reported a position in NEO in Q1 2021 and has held it in 11 quarters since. 266 funds tracked by Wall St. Rank hold NEO as of Q2 2026.

  • Huntington National Bank held 3,122 shares of NeoGenomics worth $45.5K as of Q2 2026.
  • Huntington National Bank sold 246 NeoGenomics shares in Q2 2026, an estimated $2.37K.
  • NeoGenomics made up ﹤0.01% of Huntington National Bank's portfolio in Q2 2026, its #1468 holding.
  • Huntington National Bank first reported a position in NeoGenomics in Q1 2021 and has held it in 11 quarters since.
  • 266 funds tracked by Wall St. Rank held NeoGenomics as of Q2 2026.

Based on Huntington National Bank's 13F filing for Q2 2026, filed 13 Aug 2026.